The company's B2B business has seen tremendous growth in recent years, executing more than 400 major transactions since inception and creating billions of dollars in value.

Adalvo serves a global list of top-tier partners with a differentiated, high-value product portfolio of peptides, biosimilars, added-value medicines, injectables, and cytotoxic oncology products. It has established a global reputation for quality and reliability through its close relationships with more than 90 commercial partners in more than 70 countries. Adalvo’s is headquartered in Malta, with commercial offices in more than 15 countries, including Switzerland, the UK, Netherlands, Spain, Iceland, Austria, Romania, Hungary, Bulgaria, Portugal, the Czech Republic and India.

Adalvo’s partners like to be bigger, better and smarter in the dynamic pharmaceutical sector. And Adalvo prides itself on helping its partners reach their goals – whether that's increasing revenue or entering new markets. While partner success is a constant priority, Adalvo is also committed to the well-being and development of its employees and the communities in which it works. The company has a strong organizational culture, striving tirelessly for excellence in everything it does and driven by a passion for making a difference and to improving the lives of patients around the world.

The Adalvo leadership team's experience and decades of industry know-how are the foundation of its reputation as a dynamic and reliable partner. The company motto 'Always on Target' reflects its dedication to creatively deliver insight and impact, redefining what's possible for customers and all its stakeholders.